Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Anemia

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    January 2018
  1. TORO L, Barrientos V, Leon P, Rojas M, et al
    Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury.
    Kidney Int. 2018 Jan 27. pii: S0085-2538(17)30854.
    PubMed     Text format     Abstract available


    June 2017
  2. SUGAHARA M, Tanaka T, Nangaku M
    Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease.
    Kidney Int. 2017 Jun 24. pii: S0085-2538(17)30305.
    PubMed     Text format     Abstract available


  3. VAN LAECKE S, Van Biesen W
    Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
    Kidney Int. 2017;91:1271-1274.
    PubMed     Text format     Abstract available


    March 2017
  4. GOODSHIP TH, Cook HT, Fakhouri F, Fervenza FC, et al
    Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Kidney Int. 2017;91:539-551.
    PubMed     Text format     Abstract available


    November 2016
  5. RHEAULT MN, Molony JT, Nevins T, Herzog CA, et al
    Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.
    Kidney Int. 2016 Nov 16. pii: S0085-2538(16)30539.
    PubMed     Text format     Abstract available


  6. WYATT CM, Drueke TB
    HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
    Kidney Int. 2016;90:923-925.
    PubMed     Text format     Abstract available


    September 2016
  7. PERGOLA PE, Spinowitz BS, Hartman CS, Maroni BJ, et al
    Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.
    Kidney Int. 2016 Sep 17. pii: S0085-2538(16)30357.
    PubMed     Text format     Abstract available


    August 2016
  8. BRIER ME, Gaweda AE
    Artificial intelligence for optimal anemia management in end-stage renal disease.
    Kidney Int. 2016;90:259-61.
    PubMed     Text format     Abstract available


    July 2016
  9. VANKALAKUNTI M, Vasavi B, Anitha A
    Intravascular large B-cell lymphoma: masquerade as membranoproliferative glomerulonephritis.
    Kidney Int. 2016;90:231-2.
    PubMed     Text format    


    June 2016
  10. BARBIERI C, Molina M, Ponce P, Tothova M, et al
    An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients.
    Kidney Int. 2016 Jun 2. pii: S0085-2538(16)30132.
    PubMed     Text format     Abstract available


    May 2016
  11. MARCELLI D, Bayh I, Merello JI, Ponce P, et al
    Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30056.
    PubMed     Text format     Abstract available


  12. WYATT CM, Drueke TB
    Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target?
    Kidney Int. 2016;89:971-3.
    PubMed     Text format     Abstract available


    March 2016
  13. KAVANAGH D, Smith-Jackson K
    Eculizumab in children with hemolytic uremic syndrome.
    Kidney Int. 2016;89:537-8.
    PubMed     Text format     Abstract available


  14. GREENBAUM LA, Fila M, Ardissino G, Al-Akash SI, et al
    Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
    Kidney Int. 2016;89:701-11.
    PubMed     Text format     Abstract available


    November 2015
  15. MACDOUGALL IC
    Supplemental iron via dialysate: a novel mode of delivery for hemodialysis patients.
    Kidney Int. 2015;88:946-949.
    PubMed     Text format     Abstract available


    October 2015
  16. DRUEKE TB, Massy ZA
    Oral or intravenous iron for anemia correction in chronic kidney disease?
    Kidney Int. 2015;88:673-5.
    PubMed     Text format     Abstract available


    September 2015
  17. GERL K, Miquerol L, Todorov VT, Hugo CP, et al
    Inducible glomerular erythropoietin production in the adult kidney.
    Kidney Int. 2015 Sep 23. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


    June 2015
  18. AGARWAL R, Kusek JW, Pappas MK
    A randomized trial of intravenous and oral iron in chronic kidney disease.
    Kidney Int. 2015 Jun 17. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


  19. BARADHI KM, Ahmed S, Buford ML
    The Case | Acute renal failure after antibiotic treatment for bronchitis. Diagnosis: Pigment nephropathy from cephalexin-induced immune hemolytic anemia.
    Kidney Int. 2015;87:1269-70.
    PubMed     Text format    


    May 2015
  20. LICHT C, Greenbaum LA, Muus P, Babu S, et al
    Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.
    Kidney Int. 2015;87:1061-73.
    PubMed     Text format     Abstract available


  21. NESTER CM
    Managing atypical hemolytic uremic syndrome: chapter 2.
    Kidney Int. 2015;87:882-4.
    PubMed     Text format     Abstract available


    January 2015
  22. BAILIE GR, Larkina M, Goodkin DA, Li Y, et al
    Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality.
    Kidney Int. 2015;87:162-8.
    PubMed     Text format     Abstract available


    August 2014
  23. PICCOLI GB, Roggero S, De Pascale A, Vigotti FN, et al
    Microhematuria in a patient with beta-thalassemia major: a casual or a causal association?
    Kidney Int. 2014;86:450-2.
    PubMed     Text format    


    April 2014
  24. KURAGANO T, Matsumura O, Matsuda A, Hara T, et al
    Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients.
    Kidney Int. 2014 Apr 23. doi: 10.1038/ki.2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: